Amastatin
An inhibitor of aminopeptidases
| Amastatin | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Amastatin is a potent inhibitor of aminopeptidases, a class of enzymes that catalyze the cleavage of amino acids from the amino terminus of protein or peptide substrates. It is primarily used in biochemical research to study the role of aminopeptidases in various biological processes.
Structure and Properties
Amastatin is a naturally occurring peptide that was originally isolated from the culture broth of the bacterium Streptomyces species. It is a small molecule with a specific structure that allows it to bind effectively to the active site of aminopeptidases, thereby inhibiting their activity.
Mechanism of Action
Amastatin functions by binding to the active site of aminopeptidases, preventing the enzyme from interacting with its natural substrates. This inhibition is crucial for studying the physiological roles of aminopeptidases, as it allows researchers to observe the effects of reduced enzyme activity in various biological systems.
Applications in Research
Amastatin is widely used in biochemical and pharmacological research. It is particularly useful in studies involving the regulation of peptide hormones and neuropeptides, as aminopeptidases play a significant role in the metabolism of these molecules. By inhibiting aminopeptidases, researchers can investigate the pathways and mechanisms through which these peptides exert their effects.
Biological Significance
Aminopeptidases are involved in numerous physiological processes, including the maturation and degradation of proteins, the regulation of blood pressure, and the modulation of immune responses. Amastatin, by inhibiting these enzymes, provides insights into their function and potential as therapeutic targets in various diseases.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD